Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2

Andrew Motlis, Moheb Boktor, Paul Jordan, Urska Cvek, Marjan Trutschl, J. Steven Alexander

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2'. Together they form a unique fingerprint.

Medicine & Life Sciences